ABIRATERONE ACETATE
Abiraterone acetate. Endocrine therapy. Other hormone antagonists and related agents.
APIXA
Antithrombotic agents, direct factor Xa inhibitors
B-MAB
Bevacizumab. Antineoplastic agents. Monoclonal antibodies.
BENDAMUSTINE
Bendamustine. Antineoplastic agents. Alkylating agents.
BORTEZOMAC
Bortezomib. Antineoplastic agents. Other antineoplastic agents.
BOZENTAN
Bosentan. Antihypertensives for pulmonary arterial hypertension.
ERLOTINIB
Erlotinib. Antineoplastic agents. Protein kinase inhibitors.
FLUCONAZOLE
Fluconazole. Antimycotics for systemic use. Triazole derivatives.
GEFITINIB
Gefitinib. Antineoplastic agents. Protein kinase inhibitors.
GLATIRAMER ACETATE
Glatiramer acetate. Solution for subcutaneous injection. Other immunostimulants.
HEPCINAT
Sofosbuvir. Antiviral for systemic use. Direct acting antivirals.
INFLIMAB
Infliximab. Immunosupressant. Tumor necrosis factor alpha (TNF-α) inhibitors.
LENALIDOMIDE
Lenalidomide. Other immunosuppressants.
LETROZAK
Letrozole. Endocrine therapy. Hormone antagonist and related agents.
R-MAB
Rituximab. Antineoplastic agents. Monoclonal antibodies.
T-MAB
Trastuzumab. Antineoplastic agents. Monoclonal antibodies.
VELPANAT
Sofosbuvir/Velpatasvir. Antiviral for systemic use. Direct acting antivirals.
VORICONAZOLE
Voriconazole. Antimycotics for systemic use. Triazole derivatives. Sofosbuvir. Antivirals for treatment of HCV infections